Resmed Inc. buy Morgan Stanley
Start price
21.10.25
/
50%
€230.40
Target price
21.10.26
€261.08
Performance (%)
-15.80%
Price
14.08.26
€194.00
Summary
This prediction is currently active. The prediction for Resmed Inc. disappoints with a performance of -15.80%. This prediction currently runs until 21.10.26. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Resmed Inc. | 5.780% | 5.780% |
| iShares Core DAX® | 0,44 % | 5,64 % |
| iShares Nasdaq 100 | 1,06 % | 0,28 % |
| iShares Nikkei 225® | 1,77 % | 0,41 % |
| iShares S&P 500 | 0,37 % | 1,92 % |
Comments by Morgan_Stanley for this prediction
In the thread Resmed Inc. diskutieren
ResMed (NYSE:RMD) had its price target raised by analysts at Morgan Stanley from $298.00 to $304.00. They now have an "overweight" rating on the stock.
Ratings data for RMD provided by MarketBeat